896
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of auricular lymph node cell lymphocyte proliferation and cytokine production as non-radioactive endpoints during murine contact allergy

, , &
Pages 131-139 | Received 19 Oct 2010, Accepted 11 Dec 2010, Published online: 31 Jan 2011

References

  • Azam, P., Peiffer, J. L., Ourlin, J. C., Bonnet, P. A., Tissier, M. H., Vian, L., and Fabre, I. 2005. Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 production. Toxicology. 206:285–298.
  • Basketter, D. A., Gerberick, F., and Kimber, I. 2007. The local lymph node assay and the assessment of relative potency: Status of validation. Contact Derm. 57:70–75.
  • Basketter, D. A., Gerberick, G. F., Kimber, I., and Loveless, S. E. 1996. The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem. Toxicol. 34:985–997.
  • Basketter, D. A., Lea, L. J., Cooper, K., Stocks, J., Dickens, A., Pate, I., Dearman, R. J., and Kimber, I. 1999a. Threshold for classification as a skin sensitizer in the local lymph node assay: A statistical evaluation. Food Chem. Toxicol. 37:1167–1174.
  • Basketter, D. A., Lea, L. J., Dickens, A., Briggs, D., Pate, I., Dearman, R. J., and Kimber, I. 1999b. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 19:261–266.
  • Basketter, D. A., Wright, Z. M., Warbrick, E. V., Dearman, R. J., Kimber, I., Ryan, C. A., Gerberick, G. F., and White, I. R. 2001. Human potency predictions for aldehydes using the local lymph node assay. Contact Derm. 45:89–94.
  • Basketter, D., Ball, N., Cagen, S., Carrillo, J. C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R., and Mehling, A. 2009. Application of a weight of evidence approach to assessing discordant sensitisation datasets: Implications for REACH. Regul. Toxicol. Pharmacol. 55:90–96.
  • Berg, D. J., Leach, M. W., Kühn, R., Rajewsky, K., Müller, W., Davidson, N. J., and Rennick, D. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99–108.
  • Betts, C. J., Dearman, R. J., Heylings, J. R., Kimber, I., and Basketter, D. A. 2006. Skin sensitization potency of methyl methacrylate in the local lymph node assay: Comparisons with guinea-pig data and human experience. Contact Derm. 55:140–147.
  • Biedermann, T., Mailhammer, R., Mai, A., Sander, C., Ogilvie, A., Brombacher, F., Maier, K., Levine, A. D., and Rö cken, M. 2001. Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific TH2 cells. Eur. J. Immunol. 31:1582–1591.
  • Boussiquet-Leroux, C., Durand-Cavagna, G., Herlin, K., and Holder, D. 1995. Evaluation of lymphocyte proliferation by immunohistochemistry in the local lymph node assay. J. Appl. Toxicol. 15:465–475.
  • Brent, J. A., Bojko, C. H., and Hollander, V. P. 1977. Toxicity of 5-bromo-2′-deoxyuridine to malignant lymphoid cell lines. Proc. Soc. Exp. Biol. Med. 154:160–163.
  • Campos, R. A., Szczepanik, M., Itakura, A., Akahira-Azuma, M., Sidobre, S., Kronenberg, M., and Askenase, P. W. 2003. Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T-cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198:1785–1796.
  • De Jong, W. H., Arts, J. H., De Klerk, A., Schijf, M. A., Ezendam, J., Kuper, C. F., and Van Loveren, H. 2009. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology. 261:103–111.
  • Dearman, R. J., Basketter, D. A., and Kimber, I. 1996a. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice. Toxicol. Appl. Pharmacol. 138:308–316.
  • Dearman, R. J., Moussavi, A., Kemeny, D. M., and Kimber, I. 1996b. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 89:502–510.
  • Dearman, R. J., Betts, C. J., Humphreys, N., Flanagan, B. F., Gilmour, N. J., Basketter, D. A., and Kimber, I. 2003. Chemical allergy: Considerations for the practical application of cytokine profiling. Toxicol. Sci. 71:137–145.
  • Dearman, R. J., Hilton, J., Basketter, D. A., and Kimber, I. 1999. Cytokine endpoints for the local lymph node assay: Consideration of IFNγ and IL-12. J. Appl. Toxicol. 19:149–155.
  • Dearman, R. J., Scholes, E. W., Ramdin, L. S., Basketter, D. A., and Kimber, I. 1994. The local lymph node assay: an interlaboratory evaluation of interleukin 6 (IL-6) production by draining lymph node cells. J. Appl. Toxicol. 14:287–291.
  • European Centre for the Validation of Alternative Methods (ECVAM). 2000. Statement on the validity of the local lymph node assay for skin sensitization testing. ATLA 28:366–367.
  • Fong, T. A., and Mosmann, T. R. 1989. The role of IFN-γ in delayed-type hypersensitivity mediated by TH1 clones. J. Immunol. 143:2887–2893.
  • Gerberick, G. F., Ryan, C. A., Dearman, R. J., and Kimber, I. 2007. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods. 41:54–60.
  • Hardy, R. R., and Hayakawa, K. 1994. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55:297–339.
  • Hayashi, M., Higashi, K., Kato, H., and Kaneko, H. 2001. Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: Comparison of two mouse strains, C57BL/6 and BALB/c. Toxicol. Appl. Pharmacol. 177:38–45.
  • Hitoshi, Y., Yamaguchi, N., Korenaga, M., Mita, S., Tominaga, A., and Takatsu, K. 1991. In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice. Int. Immunol. 3:135–139.
  • Homey, B., von Schilling, C., Blümel, J., Schuppe, H. C., Ruzicka, T., Ahr, H. J., Lehmann, P., and Vohr, H. W. 1998. An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions. Toxicol. Appl. Pharmacol. 153:83–94.
  • Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Report. 1999. The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/compounds. Bethesda, MD: NIH Publication No. 99–4494.
  • Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Report March 2010. ICCVAM Test Method Evaluation Report on the Murine Local Lymph Node Assay: BrdU-ELISA A Non-radioactive Alternative Test Method to Assess the Allergic Contact Dermatitis Potential of Chemicals and Products. <http://iccvam.niehs.nih.gov/methods/immunotox/llna-ELISA/TMER.htm>
  • Itakura, A., Kikuchi, Y., Kouro, T., Ikutani, M., Takaki, S., Askenase, P. W., and Takatsu, K. 2006. Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells. Int. Arch. Allergy Immunol. 140 Suppl 1:8–16.
  • Kimber, I., and Basketter, D. A. 1992. The murine local lymph node assay: A commentary on collaborative studies and new directions. Food Chem. Toxicol. 30:165–169.
  • Kimber, I., and Weisenberger, C. 1989. A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study. Arch. Toxicol. 63:274–282.
  • Kimber, I., Gerberick, G F., van Loveren, H., and House R, V. 1992. Chemical allergy: Molecular mechanisms and practical applications. Fundam. Appl. Toxicol. 19:479–483.
  • Kimber, I., Basketter, D. A., Butler, M., Gamer, A., Garrigue, J. L., Gerberick, G. F., Newsome, C., Steiling, W., and Vohr, H. W. 2003. Classification of contact allergens according to potency: Proposals. Food Chem. Toxicol. 41:1799–1809.
  • Kimber, I., Dearman, R. J., Basketter, D. A., Ryan, C. A., and Gerberick, G. F. 2002. The local lymph node assay: Past, present and future. Contact Derm. 47:315–328.
  • Ku, H. O., Jeong, S. H., Kang, H. G., Pyo, H. M., Cho, J. H., Son, S. W., Kim, H. R., Lee, K. J., and Ryu, D. Y. 2008. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers. Toxicology 250:116–123.
  • Lee, J. K., Park, J. H., Park, S. H., Kim, H. S., and Oh, H. Y. 2002. A non-radioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry. J. Pharmacol. Toxicol. Methods. 48:53–61.
  • Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G., and Vadas, M. A. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219–224.
  • Manetz, T. S., and Meade, B. J. 1999. Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T-cell-mediated hypersensitivity responses. Toxicol. Sci. 48:206–217.
  • Manetz, T. S., Pettit, D. A., and Meade, B. J. 2001. The determination of draining lymph node cell cytokine mRNA levels in BALB/c mice following dermal sodium lauryl sulfate, dinitrofluorobenzene, and toluene diisocyanate exposure. Toxicol. Appl. Pharmacol. 171:174–183.
  • Plitnick, L. M., Loveless, S. E., Ladics, G. S., Holsapple, M. P., Selgrade, M. J., Sailstad, D. M., and Smialowicz, R. J. 2002. Cytokine profiling for chemical sensitizers: Application of the ribonuclease protection assay and effect of dose. Toxicol. Appl. Pharmacol. 179:145–154.
  • Plytycz, B., and Seljelid, R. 2002. Stress and immunity: Minireview. Folia Biol. (Krakow). 50:181–189.
  • Romagnani, S. 1991. Human TH1 and TH2 subsets: Doubt no more. Immunol. Today. 12:256–257.
  • Roupe, G., and Ridell, B. 1979. The cellular infiltrate in contact hypersensitivity to picryl chloride in the mouse. Acta Derm. Venereol. 59:191–195.
  • Rowe, A., and Bunker, C. B. 1998. Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis. Contact Derm. 38:36–39.
  • Suda, A., Yamashita, M., Tabei, M., Taguchi, K., Vohr, H. W., Tsutsui, N., Suzuki, R., Kikuchi, K., Sakaguchi, K., Mochizuki, K., and Nakamura, K. 2002. Local lymph node assay with non-radioisotope alternative endpoints. J. Toxicol. Sci. 27:205–218.
  • Takeyoshi, M., Noda, S., Yamasaki, K., and Kimber, I. 2006. Advantage of using CBA/N strain mice in a non-radioisotophic modification of the local lymph node assay. J. Appl. Toxicol. 26:5–9.
  • Takeyoshi, M., Yamasaki, K., Yakabe, Y., Takatsuki, M., and Kimber, I. 2001. Development of non-radio isotopic endpoint of murine local lymph node assay based on 5-bromo-2′-deoxyuridine (BrdU) incorporation. Toxicol. Lett. 119:203–208.
  • Traidl, C., Jugert, F., Krieg, T., Merk, H., and Hunzelmann, N. 1999. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J. Invest. Dermatol. 112:476–482.
  • Tsuji, R. F., Szczepanik, M., Kawikova, I., Paliwal, V., Campos, R. A., Itakura, A., Akahira-Azuma, M., Baumgarth, N., Herzenberg, L. A., and Askenase, P. W. 2002. B-cell-dependent T-cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196:1277–1290.
  • Ulrich, P., Grenet, O., Bluemel, J., Vohr, H. W., Wiemann, C., Grundler, O., and Suter, W. 2001. Cytokine expression profiles during murine contact allergy: T-helper 2 cytokines are expressed irrespective of the type of contact allergen. Arch. Toxicol. 75:470–479.
  • Vandebriel, R. J., de Jong, W. H., Spiekstra, S. W., van Dijk, M., Fluitman, A., Garssen, J., and van Loveren, H. 2000. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for IFNγ and IL-4. Toxicol. Appl. Pharmacol. 162:77–85.
  • Vandebriel, R. J., De Jong, W. H., Hendriks, J. J., and Van Loveren, H. 2003. Impact of exposure duration by low molecular weight compounds on interferon-γ and interleukin-4 mRNA expression and production in the draining lymph nodes of mice. Toxicology 188:1–13.
  • Van Och, F. M., Van Loveren, H., De Jong, W. H., and Vandebriel, R. J. 2002. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: An approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol. Appl. Pharmacol. 184:46–56.
  • Vohr, H. W., Blumel, J., Blotz, A., Homey, B., and Ahr, H. J. 2000. An intra-laboratory validation of the Integrated Model for the Differentiation of Skin Reactions (IMDS): discrimination between (photo)allergic and (photo)irritant skin reactions in mice. Arch. Toxicol. 73:501–509.
  • Xu, H., DiIulio, N. A., and Fairchild, R. L. 1996. T-Cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: Interferon γ -producing (Tc1) effector CD8+ T cells and interleukin (IL) 4/IL-10-producing (TH2) negative regulatory CD4+ T-cells. J. Exp. Med. 183:1001–1012.
  • Yamaguchi, Y., Suda, T., Suda, J., Eguchi, M., Miura, Y., Harada, N., Tominaga, A., and Takatsu, K. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.